biospecimen_aliquot__bcr_aliquot_barcode	tcga-bh-a0dv-01a-21d-a12q-09
biospecimen_aliquot__bcr_aliquot_uuid	24ee6b1d-3594-4d12-91b3-8ad1b3c98f28
biospecimen_aliquot__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_aliquot__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_aliquot__biospecimen_barcode_bottom	0108431835
biospecimen_aliquot__center_id	09
biospecimen_aliquot__concentration	0.08
biospecimen_aliquot__date_of_shipment	2011-02-22
biospecimen_aliquot__is_derived_from_ffpe	no
biospecimen_aliquot__plate_column	4
biospecimen_aliquot__plate_id	a12q
biospecimen_aliquot__plate_row	f
biospecimen_aliquot__quantity	3.20
biospecimen_aliquot__source_center	23
biospecimen_aliquot__volume	40.00
biospecimen_analyte__a260_a280_ratio	1.82
biospecimen_analyte__analyte_type	dna
biospecimen_analyte__analyte_type_id	d
biospecimen_analyte__bcr_analyte_barcode	tcga-bh-a0dv-01a-21d
biospecimen_analyte__bcr_analyte_uuid	329a42e7-bd64-47f2-8a90-f9bcee53043a
biospecimen_analyte__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_analyte__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_analyte__concentration	0.16
biospecimen_analyte__gel_image_file	https://sharedoc.nchri.org/tcga-bcr/default.aspx
biospecimen_analyte__is_derived_from_ffpe	no
biospecimen_analyte__normal_tumor_genotype_match	yes
biospecimen_analyte__pcr_amplification_successful	yes
biospecimen_analyte__spectrophotometer_method	uv spec
biospecimen_analyte__subportion_sequence	1
biospecimen_diagnostic_slides__bcr_patient_barcode	tcga-bh-a0dv
biospecimen_diagnostic_slides__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_diagnostic_slides__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_diagnostic_slides__ffpe_slide_uuid	2f0b5fb3-40f0-4d27-bfac-390fb9a42b39
biospecimen_normal_control__bcr_patient_barcode	tcga-bh-a0dv
biospecimen_normal_control__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_normal_control__normal_tissue_anatomic_site	breast
biospecimen_portion__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_portion__bcr_portion_barcode	tcga-bh-a0dv-01a-21
biospecimen_portion__bcr_portion_uuid	986aee21-a911-46ff-9088-31a0c78b89b7
biospecimen_portion__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_portion__date_of_creation	2010-06-04
biospecimen_portion__is_ffpe	no
biospecimen_portion__portion_number	21
biospecimen_portion__portion_sequence	2
biospecimen_portion__weight	30.00
biospecimen_protocol__bcr_analyte_barcode	tcga-bh-a0dv-01a-21d
biospecimen_protocol__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_protocol__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_protocol__experimental_protocol_type	adna preparation type
biospecimen_sample__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_sample__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_sample__bcr_sample_uuid	b4c19f4e-c5bf-4c4f-bad8-9c18128c112d
biospecimen_sample__days_to_collection	975
biospecimen_sample__initial_weight	370
biospecimen_sample__is_ffpe	no
biospecimen_sample__oct_embedded	true
biospecimen_sample__pathology_report_file_name	tcga-bh-a0dv.3a0e1ef6-b234-46ec-bd15-95b5fab06d45.pdf
biospecimen_sample__pathology_report_uuid	3a0e1ef6-b234-46ec-bd15-95b5fab06d45
biospecimen_sample__sample_type	primary tumor
biospecimen_sample__sample_type_id	01
biospecimen_sample__vial_number	a
biospecimen_shipment_portion__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_shipment_portion__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_shipment_portion__bcr_shipment_portion_uuid	2ddc51b1-8ac4-4b9e-85d3-23c698917d5f
biospecimen_shipment_portion__center_id	20
biospecimen_shipment_portion__is_ffpe	no
biospecimen_shipment_portion__plate_id	a13b
biospecimen_shipment_portion__portion_number	11
biospecimen_shipment_portion__portion_sequence	1
biospecimen_shipment_portion__shipment_portion_bcr_aliquot_barcode	tcga-bh-a0dv-01a-11-a13b-20
biospecimen_shipment_portion__shipment_portion_day_of_shipment	22
biospecimen_shipment_portion__shipment_portion_month_of_shipment	3
biospecimen_shipment_portion__shipment_portion_year_of_shipment	2011
biospecimen_slide__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
biospecimen_slide__bcr_sample_barcode	tcga-bh-a0dv-01a
biospecimen_slide__bcr_slide_barcode	tcga-bh-a0dv-01a-02-bsb
biospecimen_slide__bcr_slide_uuid	391712b1-566f-432f-88d8-44067bfcfc6d
biospecimen_slide__image_file_name	tcga-bh-a0dv-01a-02-bsb.391712b1-566f-432f-88d8-44067bfcfc6d.svs
biospecimen_slide__is_derived_from_ffpe	no
biospecimen_slide__percent_lymphocyte_infiltration	7
biospecimen_slide__percent_monocyte_infiltration	0
biospecimen_slide__percent_necrosis	2
biospecimen_slide__percent_neutrophil_infiltration	0
biospecimen_slide__percent_normal_cells	8
biospecimen_slide__percent_stromal_cells	45
biospecimen_slide__percent_tumor_cells	45
biospecimen_slide__percent_tumor_nuclei	70
biospecimen_slide__section_location	bottom
biospecimen_tumor_sample__bcr_patient_barcode	tcga-bh-a0dv
biospecimen_tumor_sample__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
clinical_drug__bcr_drug_barcode	tcga-bh-a0dv-d63674
clinical_drug__bcr_drug_uuid	6d3d306f-fa11-4aed-93f7-6388aee8f089
clinical_drug__bcr_patient_barcode	tcga-bh-a0dv
clinical_drug__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
clinical_drug__form_completion_date	2014-8-15
clinical_drug__pharmaceutical_therapy_drug_name	adriamycin
clinical_drug__pharmaceutical_therapy_type	chemotherapy
clinical_drug__pharmaceutical_tx_ended_days_to	177
clinical_drug__pharmaceutical_tx_ongoing_indicator	no
clinical_drug__pharmaceutical_tx_started_days_to	48
clinical_drug__treatment_best_response	complete response
clinical_drug__tx_on_clinical_trial	no
clinical_follow_up__bcr_followup_barcode	tcga-bh-a0dv-f63672
clinical_follow_up__bcr_followup_uuid	39c1b260-0c00-4d1c-93d1-6f57ab835dd1
clinical_follow_up__bcr_patient_barcode	tcga-bh-a0dv
clinical_follow_up__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
clinical_follow_up__followup_lost_to	no
clinical_follow_up__form_completion_date	2014-8-15
clinical_follow_up__last_contact_days_to	2064
clinical_follow_up__new_tumor_event_dx_indicator	no
clinical_follow_up__pharmaceutical_tx_adjuvant	yes
clinical_follow_up__radiation_treatment_adjuvant	yes
clinical_follow_up__tumor_status	tumor free
clinical_follow_up__vital_status	alive
clinical_patient__age_at_diagnosis	54
clinical_patient__ajcc_metastasis_pathologic_pm	m0
clinical_patient__ajcc_nodes_pathologic_pn	n2a
clinical_patient__ajcc_pathologic_tumor_stage	stage iiia
clinical_patient__ajcc_staging_edition	6th
clinical_patient__ajcc_tumor_pathologic_pt	t2
clinical_patient__anatomic_neoplasm_subdivision	left upper inner quadrant|left lower inner quadrant|left lower outer quadrant|left
clinical_patient__bcr_patient_barcode	tcga-bh-a0dv
clinical_patient__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
clinical_patient__birth_days_to	-19781
clinical_patient__days_to_initial_pathologic_diagnosis	0
clinical_patient__er_status_by_ihc	positive
clinical_patient__form_completion_date	2011-8-2
clinical_patient__gender	female
clinical_patient__her2_status_by_ihc	negative
clinical_patient__histological_type	infiltrating ductal carcinoma
clinical_patient__history_neoadjuvant_treatment	no
clinical_patient__history_other_malignancy	no
clinical_patient__icd_10	c50.9
clinical_patient__icd_o_3_histology	8500/3
clinical_patient__icd_o_3_site	c50.9
clinical_patient__informed_consent_verified	yes
clinical_patient__initial_pathologic_dx_year	2007
clinical_patient__last_contact_days_to	1374
clinical_patient__lymph_nodes_examined	yes
clinical_patient__lymph_nodes_examined_count	9
clinical_patient__lymph_nodes_examined_he_count	9
clinical_patient__margin_status	negative
clinical_patient__menopause_status	peri (6-12 months since last menstrual period)
clinical_patient__metastatic_tumor_indicator	no
clinical_patient__method_initial_path_dx	core needle biopsy
clinical_patient__patient_id	a0dv
clinical_patient__pr_status_by_ihc	positive
clinical_patient__prospective_collection	no
clinical_patient__race	white
clinical_patient__retrospective_collection	yes
clinical_patient__surgical_procedure_first	modified radical mastectomy
clinical_patient__tissue_source_site	bh
clinical_patient__tumor_status	tumor free
clinical_patient__tumor_tissue_site	breast
clinical_patient__vital_status	alive
clinical_radiation__bcr_patient_barcode	tcga-bh-a0dv
clinical_radiation__bcr_patient_uuid	96b9c7db-1be1-4b60-b47c-26b654c3d64c
clinical_radiation__bcr_radiation_barcode	tcga-bh-a0dv-r63676
clinical_radiation__bcr_radiation_uuid	4bea7c33-55a3-42b7-97e0-d43f494c6b9d
clinical_radiation__form_completion_date	2014-8-15
clinical_radiation__radiation_adjuvant_fractions_total	33
clinical_radiation__radiation_adjuvant_units	cgy
clinical_radiation__radiation_therapy_ended_days_to	223
clinical_radiation__radiation_therapy_ongoing_indicator	no
clinical_radiation__radiation_therapy_site	primary tumor field
clinical_radiation__radiation_therapy_started_days_to	177
clinical_radiation__radiation_therapy_type	external
clinical_radiation__radiation_total_dose	6040
clinical_radiation__treatment_best_response	complete response
manually_curated__center	genome.wustl.edu
manually_curated__dataType	dnaseq
manually_curated__exp_data_bed_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0DV-01A-21D-A12Q-09.bed
manually_curated__exp_metadata_url	ftp://bioinf.iasi.cnr.it/bed/brca/dnaseq/TCGA-BH-A0DV-01A-21D-A12Q-09.bed.meta
manually_curated__id	tcga-bh-a0dv-01a-21d-a12q-09
manually_curated__md5sum	e0b14b8ca36eb11b0a82c190b7a80d7f
manually_curated__ncbi_build	37
manually_curated__seqPlatform	illumina_ga2
manually_curated__sequence_source	wxs
manually_curated__sequencer	illumina gaiix
manually_curated__tissue_status	tumoral
manually_curated__tumor_description	breast invasive carcinoma
manually_curated__tumor_sample_uuid	24ee6b1d-3594-4d12-91b3-8ad1b3c98f28
manually_curated__tumor_tag	brca
